NCT01221389View on ClinicalTrials.gov

Study Using Plasma for Patients Requiring Emergency Surgery

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

March 31, 2013

Conditions
Hemorrhagic ShockBlood Coagulation DisordersBlood ProductsTraumaRuptured AAA
Interventions
DRUG

Human Plasma

Patients will receive either 2 units of AB+ plasma or 2 units of hydroxyethylated starch control solution once they are sent to the OR for emergency surgery to address etiology for hemorrhagic shock.

Trial Locations (1)

K1Y4E9

The Ottawa Hospital, Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER